ArticleNaunyn-Schmiedeberg's archives of pharmacology2012

Tegaserod in the treatment of constipation-predominant irritable bowel syndrome. Do the risks outweigh the benefits?

Peter WoodPubMed ↗Publisher ↗

No numbers read from the abstract.